Provided by Tiger Trade Technology Pte. Ltd.

Dianthus Therapeutics Inc.

103.28
-3.7600-3.51%
Post-market: 103.280.00000.00%19:58 EDT
Volume:535.82K
Turnover:56.17M
Market Cap:5.78B
PE:-25.11
High:107.64
Open:105.88
Low:101.60
Close:107.04
52wk High:117.88
52wk Low:32.22
Shares:55.93M
Float Shares:55.85M
Volume Ratio:0.83
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1130
EPS(LYR):-4.2037
ROE:-26.07%
ROA:-17.69%
PB:4.93
PE(LYR):-24.57

Loading ...

Dianthus Therapeutics Grants 58,000 Inducement Stock Options Priced at $90.21 Per Share

Reuters
·
Jul 03

Dianthus Therapeutics - Top-line Results from Phase 3 Emerge Trial Anticipated in 2H 2028

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics - Expects Phase 2 Momentum Trial Top-line Data in Q4 2026 and Captivate Update by Ye 2026

THOMSON REUTERS
·
Jun 29

Dianthus Therapeutics SVP, General Counsel Adam Veness disposes of USD 2.42 million in common shares

Reuters
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Jun 17

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Dianthus Therapeutics (DNTH)

TIPRANKS
·
Jun 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: Genmab (GMAB), Dianthus Therapeutics (DNTH) and Aurora Cannabis (ACB)

TIPRANKS
·
Jun 15

TD Cowen Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

TIPRANKS
·
Jun 14

Dianthus’ new CAPTIVATE responder rate beat expectations, says Raymond James

TIPRANKS
·
Jun 13

Dianthus reports additional data from Part A of CAPTIVITY study

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 13

Dianthus rises 7.7%

TIPRANKS
·
Jun 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11

Dianthus price target raised to $132 from $110 at Jefferies

TIPRANKS
·
Jun 11

Dianthus Therapeutics Down Over 9%, On Track for Largest Percent Decrease Since January 2025 -- Data Talk

Dow Jones
·
Jun 11

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Cullinan Management (CGEM)

TIPRANKS
·
Jun 11

Dianthus falls -13.7%

TIPRANKS
·
Jun 10

Dianthus sinks after Sanofi halts CIDP Phase 3 study

TIPRANKS
·
Jun 10

Dianthus Therapeutics (DNTH) Is Down 10.0% After FDA Eases Claseprubart Trials And Grants Orphan Status

Simply Wall St.
·
Jun 08